Pharma Europe

Articles

Stefan Merlo, Vice President, Commercial Development, CSL Seqirus discusses how COVID-19 has evolved the discussion of vaccines and the long-term concerns stemming from flu vaccine fatigue. 
 


Pharma 2023: Vaccines Journey to the Consumer

Rebecca Vermeulen, VP Global Patient Networks, Product Development Medical Affairs for Roche discusses how they approach patient engagement. 

Pharma 2023: Working with Patient Advocacy Groups

Lisa Henderson is the group editorial director of 

 and can be reached at lhenderson@mjhlifesciences.com.

Digital and innovation leader takes issue with the current state of pharma marketing and suggests new approaches are needed.

Pharma 2023: Marketing to the Masses

Industry insights on how pharma is faring in tapping new innovations and approaches in digital health. 

Pharma 2023: Digital Health Key Takeaways

Panel discusses what real-world evidence—and related patient-reporting technology—need to achieve to better influence payer decision-making. 

Pharma 2023: Unleash RWE Benefits Along the Value Chain

Tool highlights efforts to overcome the challenges of remote disease management in Turkey.

Pharma 2023: Roche Turkey’s Digital Platform for HCPs and Patients

Experts explore MA's evolving role and skill set in engaging effectively with clinicians and other external stakeholders.

Pharma 2023: A More Collaborative Medical Affairs 

German laws, European VBCs, and trends in China, Brazil, and Saudi Arabia are changing the way global market access works.